Geneviève D'Orsay (Geneviève d'Orsay)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

End Stage Renal Disease

Glycemic Control

Randomized Controlled Trial

Cross Sectional

Top Venues

JMIR research protocols

voluntis

This page only lists publications with an associated author ORCID identifier.

Affiliation History

voluntis

France

CMO

Publications

Camille Nevoret, Nathalie Gervaise, Brigitte Delemer, Said Bekka, Bruno Detournay, Amine Benkhelil, Amar Bahloul, Geneviève D'Orsay, Alfred Penfornis
The Effectiveness of an App (Insulia) in Recommending Basal Insulin Doses for French Patients With Type 2 Diabetes Mellitus: Longitudinal Observational Study. JMIR diabetes 8 (2023)
Camille Nevoret, Nathalie Gervaise, Brigitte Delemer, Said Bekka, Bruno Detournay, Amine Benkhelil, Amar Bahloul, Geneviève D'Orsay, Alfred Penfornis
The Effectiveness of an App (Insulia) in Recommending Basal Insulin Doses for French Patients With Type 2 Diabetes Mellitus: Longitudinal Observational Study. JMIR diabetes 8 (2023)
Camille Nevoret, Nathalie Gervaise, Brigitte Delemer, Said Bekka, Bruno Detournay, Amine Benkhelil, Amar Bahloul, Geneviève D'Orsay, Alfred Penfornis
The Effectiveness of an App (Insulia) in Recommending Basal Insulin Doses for French Patients With Type 2 Diabetes Mellitus: Longitudinal Observational Study. JMIR diabetes 8 (2023)
Camille Nevoret, Nathalie Gervaise, Brigitte Delemer, Said Bekka, Bruno Detournay, Amine Benkhelil, Amar Bahloul, Geneviève D'Orsay, Alfred Penfornis
The Effectiveness of an App (Insulia) in Recommending Basal Insulin Doses for French Patients With Type 2 Diabetes Mellitus: Longitudinal Observational Study. JMIR diabetes 8 (2023)
Nathalie Jeandidier, Lucy Chaillous, Sylvia Franc, Pierre Yves Benhamou, Pauline Schaepelynck, Hélène Hanaire, Bogdan Catargi, Anne Farret, Pierre Fontaine, Bruno Guerci, Yves Reznik, Alfred Penfornis, Sophie Borot, Pierre Serusclat, Yacine Kherbachi, Geneviève D'Orsay, Bruno Detournay, Pierre Simon, Guillaume Charpentier
DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial. JMIR research protocols 7 (4) (2018)